SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " evidence " 1,110 found 🔀 AI-powered Shuffle
Analysis: Chelsea have goals and holes
Chelsea finished in 10th place, a whopping 33 points behind Arsenal last season. While Xabi Alonso's side still have plenty of catching up to do, there was evidence in this game they will compete towards the top end of the table this time. Alonso, however, needs to get on top of his side's defensive frailties.
Evidence points to yogurt as a nutrient-dense part of healthy diets
People have been making health claims about yogurt for hundreds of years.
Scientists poured pink dye into Florida’s Lake Jackson to trace hidden water; about 1 month later, it appeared at Wakulla Spring through limestone caves
A dye was injected into a sinkhole beneath Florida's Lake Jackson and took about five weeks to reach Wakulla Spring, which was evidence that water can move between the two sites through the underground limestone aquifer. The lake is about 19 miles north of Wakulla Spring, and researchers detected distinctive Rhodamine WT dye signals at the spring 35 days after the injection, according to a 2024 study in the Journal of Cave and Karst Science.
Signant Health and Lothar Medical Sign Letter of Intent to Commercialize ALDS PRO for Clinical Trials
Signant Health, a leading provider of evidence generation solutions for clinical trials, and Lothar Medical today announced that they have signed a letter of intent outlining a planned strategic collaboration to bring Lothar Medical's next-generation pulmonary function technology to the global clinical trial market.
CTE in football players is a health crisis. It’s time for us to stop watching
A new study offers more evidence that America’s biggest sport produces life-altering head trauma. The NFL will never turn itself off, so it’s on fans to do so
Four Years of Lower Drug Prices: Real Savings, Unfinished Business
The administration is touting these agreements as proof that drug prices are coming down. However, we don’t have the evidence to back that up.
Monitoring One Health action against antimicrobial resistance in Indonesia
Ministry of Health, with support from WHO and partners, convened a national multisectoral validation meeting for Indonesia’s 2026 TrACSS submission. Representatives from human health, animal health, fisheries, food and agriculture, environment, research institutions and development partners reviewed the country’s progress on AMR, and validated evidence supporting survey responses prior to submission. In the meeting, WHO presented Indonesia’s 2025 TrACSS results and facilitated technical sessions on the 2026 survey structure, rating principles and submission process.
Trump Administration Launches Blitz to Find Elusive Voter Fraud Ahead of Midterms
The practice is exceedingly rare, but President Trump has fixated on rooting it out this year, claiming without evidence that tens of thousands of noncitizens are registered to vote.
Bristol scientists may have found first evidence of dark matter
The mysterious material has eluded scientists for nearly a century.
New evidence shows Boulder climate lab was dismantled in act of political reprisal, lawsuit alleges
New evidence shows pure politics was behind the Trump administration's threat to dismantle Boulder's NCAR climate lab, a lawsuit says
August Monthly Review: ChatGPT In Epic
Death, taxes, another frontier lab healthcare launch inspiring truly insane LinkedIn takes. As much as I want to stay away, I repeatedly am the crewman unplugging his ears whenever we pass these sirens. So it’s not the first and probably not the last time we dial up the typewriter rather than tie ourselves to the mast. The full blow-by-blow timeline: Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe The End of the Standalone PHR (Jan 8): ChatGPT Health arrives for consumers, at the time powered by b.well. I was bullish on the approach in that the best way for the PHR to finally solve distribution was to meet consumers were they already are (i.e. When Horizontal Meets Healthcare (Jan 9): OpenAI for Healthcare puts out the shingle for enterprises, with SharePoint ingestion standing in for the EHR integration the product actually needed. Another One: Anthropic’s Healthcare Debut (Jan 16): Claude's version, on HealthEx rails instead of b.well, with Agent Skills for FHIR development as the one true vertical-specific investment. ChatGPT for Clinicians: The Trap Sprung (Apr 24): OpenAI filled in the missing GTM middle with a free product for verified clinicians, effectively peeling the enterprise wrapper off ChatGPT for Healthcare and taking the PLG fight directly to OpenEvidence. OpenAI’s Second Attempt at Health (Jul 31): a relaunch of their patient specific app, now branded Health in ChatGPT, where the privacy partition came out, the connectors thinned, and b.well disappeared in favor of first-party FHIR work against a smaller network Beyond a Shingle So what was announced now? Today, we’re introducing a new electronic health record integration that brings authorized patient context from Epic into ChatGPT for Healthcare, along with the Healthcare Public Data plugin for direct, structured access to official healthcare datasets like PubMed, DailyMed, and CMS Coverage. Together, these capabilities bring ChatGPT closer to the systems and sources healthcare teams trust, while supporting the controls and compliance healthcare work requires. The core portfolio is unchanged from prior announcements we delineated and discussed (aside from the relaunch of patient-facing). Since trade publications still seem to be confusing them by using the wrong names: Enterprise sales motion: ChatGPT for Healthcare Protecting their core product / PLG: ChatGPT for Clinicians Consumer/patient-facing product: Health in ChatGPT So really, this is a feature release (specifically for ChatGPT for Healthcare when it comes to EHR integration). What’s cool about it, though, is that we are moving beyond just putting out a shingle. Everything in the January enterprise launch was horizontalizable: Horizontal tech companies thus generally start verticalization with their “putting out a shingle phase”. Telling the world you’re open for business as a horizontal tech company reliably attracts early inbound interest from buyers who are already trying to force-fit horizontal tools into domain-specific workflows and are eager for any signal that the vendor intends to support their use case more directly. Nothing was really vertical specific, which is exactly what you'd expect from the ultimate hypergrowth horizontal company dipping their toes into specific industries. But eventually you have to stop changing the sign on the door and start changing the product. Can you guess where the horizontal product was going to run out of road? This is the core dilemma writ large: verticalization requires differentiation, while scale economics of consumer and horizontal push toward unification. I’ve buried the lede so deep here it will be painful to some readers, but what should be shocking to no one is that my perspective is that EHR integration is the only path that meaningfully resolves this tension for ChatGPT for Healthcare. Integration with Microsoft Sharepoint is fine, but it is categorically insufficient for any product that hopes to influence clinical decision-making. SMART Money Well here we are, eight months later! Real vertical investment has begun, which surprised a few people. One friend in the industry messaged me: “Absolutely no way Epic gave ChatGPT API access.” Looking forensically at the announcements, the integration is notably read-only across appointment notes, laboratory results, medications, and specialist documentation. So while I’m not a betting man, I'd wager the house this is a SMART on FHIR launch: That sounds a lot like USCDI! The recommended path for the workflow they outline would be SMART on FHIR Their Health AI lead’s post is evocative of both standalone and EHR launch SMART, which another termed “ChartGPT” and “EHR Plugin” The implementation burden for SMART on FHIR is the lowest of the available integrative paths This is the team who literally did patient-facing SMART on FHIR with Epic last month Most importantly, if you’re a horizontal company, you generally still haven’t taken the full plunge and thus (overly) value reusability. SMART on FHIR is the logical compromise: healthcare-specific enough to matter, but standardized enough to reuse. Nobody Asked Judy Another friend asked “I thought they had to go to each health system, or did they go direct to Epic and now health systems opt in?” Given the trust paradigms in healthcare, this functionally cannot be Epic hoovering up all the data for OpenAI and shoving ChatGPT in their customers’ faces (or they would revolt). However, I do believe the aforementioned terrible coverage by TechCrunch and other outlets is probably responsible for that question, given the 325 million reference. When using FHIR as a business associate to an Epic customer, there is no EHR gatekeeping to speak of, as that isn’t how fhir.epic.com works: You register an app You pick your APIs You test against the sandbox APIs You list as “Ready for Production” Hospitals pick your app You test and go live with them Bluntly, nobody had to say yes or no in Verona (nor were they given the chance). Vendor Services (their next developer tier up that I doubt OpenAI is using quite yet in this initial release) certainly has contractual paperwork that some resent, but even there, the twin pressures of mounting antitrust and information blocking make outright gatekeeping increasingly fraught. My friend’s sentiment is, to me, representative of a broader industry neurosis, perhaps a sort of scar tissue of prior eras: people assume the gate is still there and never actually try the door. There are certainly other ways Epic (and any EHR) can put its thumb on the scale, but they are not so dumb as to stand in front of a federally mandated API and play bouncer at this exact moment in time. So I think they can and probably should go deeper, as this release is at best parity and at worst behind vertical-specific competition. OpenEvidence did a basic SMART launch with Sutter Health in February, allowing for more convenient evidence search by providers. They then add patient-context (the equivalent SMART on FHIR flow to what we see here) when Cedars-Sinai went enterprise-wide in May. UpToDate has four distinct applications across deeper workflows like patient engagement listed in Epic Showroom and announced a partnership with Epic to power Art at UGM Abridge and other ambient scribes have invested deeply into the deepest bidirectional clinical copilot workflow with integrations well beyond SMART on FHIR. In that light, the “Who is OpenAI primarily targeting here?” is clear. This release brings them into striking distance of OpenEvidence, but not the others quite yet. They are the only one of the three you can reach without building something truly Epic-specific. When will they go further? Competition is a great motivator to overcome the horizontal demons and start building things that can’t be reused: not across industries, not across EHRs, maybe not past the customer you built them for. That’s the price of actually verticalizing. The question is if and when OpenAI will be willing to pay it. Month in Review Here is the monthly review. As a reminder, this is a regular round-up of the month’s posts and other content to surface things you may have missed across regulation, litigation, interoperability, and beyond. AI assistance is used in these bullet summaries so I can focus on articles. Articles Published: None this month Video Content: The Information Exchange: Standards-based Thruple Edition (Aug 14): Back to school for us too, with Brad reporting in from the CMS Health Tech Ecosystem’s one year anniversary in DC. We get into the January CMS-0057 deadline, the fall rulemaking reading list, and why enrollment still keeps most apps off FHIR. The Information Exchange: Epic Dúnadan Edition (Aug 25): A UGM roundup with Ryan Brickner joining for the first time to check our takes against what the building actually thinks. Rangers, Ergo sitting on top of EHI, and a down-market lineup that needs some cuts. Regulatory: Stacked Deck, Bad Hand (Aug 05): ONC’s website refresh took the entire HIT Policy Committee record with it, so I rebuilt the archive and went looking for the regulatory capture story everyone assumes is buried in there. Stacking the deck and winning the hand turn out to be very different things. The Sixth Generation of Patient Access (Aug 19): A quick catalog of the five generations of patient access we’ve layered on since HIPAA, and the two candidates now competing to be the sixth. One is planned. The other is the market routing around the plan entirely. Court cases: Three Cases Walk Into a Docket (Aug 06): Two surprise settlements cleared the board in a single week, and then Judge Maddox dropped ninety-four pages on Vyne v. Henry Schein. The sleeper is a DMCA holding that makes direct-to-database a considerably riskier business model. Epic v. Health Gorilla: Into the MDL (Aug 10): Nine class actions are headed to Miami, and the Panel signaled it wants to bring the case that spawned them along too. That would leave Epic arguing the requests were obviously fraudulent in one courtroom and unknowable in the other. Amazon v. Perplexity: Agents Are Legalized! (Aug 11): The Ninth Circuit vacated the injunction against Comet, holding that the user is the one accessing the servers rather than the company that built the agent. A real win for agentic access, and a much narrower one than the headline suggests. Veeva v. Epic: Come At Me, Bro (Aug 26): Epic’s response brief wants the dismissal affirmed and, unusually, wants the opinion published as precedent. Buried in it is Epic’s own description of what its non-competes actually prohibit, which current and former employees should read closely. EHRs: The Contract Epic Would Never Sign Today (Aug 04): A 1999 SEC exhibit catches Epic licensing nearly its entire product line, Tapestry included, to the company that became TriZetto. The marketing services menu attached to it is the part that will make you blink. Forecast from Verona (Aug 07): The Epic Almanac makes one argument six different ways: the AI is only as good as the networks behind it. Emmie headlines, Art’s context stack is the most ambitious part, and Penny finally gets an autonomous coding date on the calendar. Works With Epic MyChart (Aug 17): Epic’s first new Showroom category since the death of Workshop certifies hardware instead of software, badge on the box and all. Made for iPhone, but for blood pressure cuffs, and rough news for anyone selling the RPM stack sitting in between. UGM Hot Takes 2026 (Aug 20): Everyone else covered the AI announcements, so I went after Savvy deleting the payment gateway, Rangers as Boost with the timer removed, and a down-market lineup with too many entries. Plus the Health Grid tidbits I cannot help myself on. MyChart Central Grows Up (Aug 24): Device data and Emmie turn Epic’s identity hub into a full consumer platform, which is both a logical answer to ChatGPT and a bit of a mistake. It also happens to be the best scraping target Epic has ever shipped. Industry Analysis: The Wrong Yardstick (Aug 12): Vertical software keeps getting judged against Superhuman and Notion, which is the wrong bar entirely. Your user is comparing your product to a whiteboard and forty phone calls before lunch. Primitives vs. Abstractions (Aug 27): Developers want building blocks, systems of record prefer to hand out business logic, and both sides have a real case. There’s no test from the outside that separates the engineering reason from the competitive one, which is why this keeps ending up in court. Cross-industry Comparisons: The Two Kinds of Platform Power (Aug 18): Attention power and record power are different problems that keep getting handed the same regulatory toolkit. Congress’s latest swing at Big Tech shows both what’s possible and where it falls apart. The Dogs of (Platform) War (Aug 21): A CourtListener alert turned up a property management fight with healthcare’s exact shape and none of the Cures Act. Shell prospects, ghost accounts, a notetaker bot that came back to haunt someone, and a lawyer arguing both sides of the same theory in two states. Fractals All the Way Down (Aug 31): Yardi dominates property management right up until you zoom into one segment, where AppFolio owns it outright and Yardi doesn’t appear at all. Where you draw the line around a B2B software market is about to decide an awful lot of cases. Other News: If Judy Had the Courage (Aug 13): A short eulogy for the era when software was allowed to look insane: WinAMP, bold colors, and everything the grey chatbot era has taken from us. External Media: Portland Monthly Health Tech Meetup: Erin O’Brien channeled my own feelings - maybe it’s just because it’s August and beautiful, but the monthly edition of the PDX Health community meetup was a ripper. Make sure to reach out if interested to join for the next one. STAT’s Coverage of Epic This Month: Brittany Trang of STAT did a fantastic job of breaking the FTC investigation that’s been lurking, as well as UGM related coverage, so I had to give her her wish of a meme. Fall Conferences: I’m pumped to be kicking off my fall conference season in NYC at Nabla Accelerate next month, which Chrissy provided the link to apply for. Here’s the rest of my schedule in case you want to meet up: Commonwell (Redwood Shores, CA): Oct 13-14 Open@Epic (Madison, WI): Oct 21-22 eHealthExchange (Austin, TX): Oct 27 Sequoia Project (Austin, TX): Oct 28-29 HLTH (Vegas): Nov 15-18 RSNA (Chicago): Nov 29-Dec 3 Posts I Liked: HTI-6 Should Unbundle API Certification: Josh Mandel makes the case that HTI-6 should split (g)(10) into separate authorization and data certifications, so a PACS or a genomics platform can certify only the role it actually performs. Imaging is the urgent example, but the structure solves a much bigger problem. On implementing ePrior Auth with Epic: Scott Rossignol’s field notes from a live ePrior Auth build on Epic, including the two app registrations nobody warns you about and the CPT mapping problem waiting at the end. CMS-0057 implementations are going to be such a beast. Healthcare point solutions are starting to look a lot like streaming services: Spencer Dorn runs the cable-to-streaming arc against health IT and lands squarely on the bundling half of the cycle. Bundling can be good! It can also be bad! Life is nuanced. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Women's health
The European Medicines Agency (EMA) works to ensure that the needs of women are considered throughout the development, evaluation and use of medicines in the European Union (EU). This includes promoting appropriate representation in clinical research, providing guidance to medicine developers, improving knowledge on medicine use during pregnancy and breastfeeding, and generating real world evidence on women's health.
A search for one exotic particle uncovered two strange new structures
A search for one mysterious particle unexpectedly revealed evidence for two different structures that may belong to the bizarre family of exotic subatomic particles known as XYZ states. The findings could help physicists uncover new ways that quarks and gluons combine to create matter.
New Detection In Dark Matter Experiment Has Physicists Excited – Is It An Unexpected And Rare Background Or The First Evidence Of Dark Matter?
The detection is far from the gold standard threshold, but it is also in a mass region that shouldn’t have events.
Growth hormone peptides promise to stall aging—but does the science stack up?
Sermorelin, tesamorelin and other growth hormone peptides are being touted as antiaging elixirs, but what evidence is behind those claims?
Four popular supplements that science says don't deliver
Walk into the supplement aisle and you’ll find plenty of products promising better health. But sometimes, basic chemistry and biology tell us those claims simply don’t add up. Before spending money on the next supplement promising better memory, faster recovery, or improved health, look beyond the label and examine the evidence.
Positive and Near-Positive Aspects of Designer Science
In C. W. Howell’s mind, intelligent design is still recovering from the Dover trial, and if there’s evidence to the contrary, he doesn’t want to see it.
Is Swansea City's attacking transfer business already paying off?
Swansea fans were keen to see signings on the wing, and on the evidence of the first three Championship games, the additions have paid dividends.
RFK Jr. wanted ‘gold standard’ science. mRNA just delivered it
Recent mRNA milestones prove public health policy must be driven by gold-standard evidence rather than political ideology.
Integrated pollution and carbon mitigation delivers major health and economic cobenefits in China
Synergistic mitigation of air pollutants and greenhouse gases is crucial for achieving clean air and carbon neutrality, but quantitative evidence of sectoral and regional health co-benefits in China remains limited. Authors develop an integrated Energy-Economy-Air Quality-Health framework coupling CEEPA, GAINS, and a province-level health module to simulate fourteen policy scenarios from 2020 to 2050. Coordinated strategies reduce CO2 and pollutants (SO2, NOX, PM2.5) by 75% relative to 2020, avoiding more than 500,000 premature deaths by 2050 and yielding monetized gains of 1.07 trillion CNY. Health benefits concentrate in industrially dense and populous provinces, with near-term PM2.5 reductions driven by pollution control and long-term improvements reliant on decarbonization. The integrated approach achieves a benefit-to-cost ratio of 1.42, lowering abatement costs by 11% relative to pollution-only measures. These findings highlight the value of coordinated, sector- and region-specific strategies for simultaneous climate mitigation, air quality improvement, and public health protection.
The universe is still speeding up, but nobody knows why
A major new analysis challenges recent claims that the universe's expansion is slowing, finding that the evidence for cosmic acceleration remains strong. The findings preserve the leading role of dark energy, while leaving scientists with the enduring mystery of what this strange cosmic force actually is.
NYC health department announces 2 more deaths linked to Legionnaires' outbreak
Officials said there is no evidence of ongoing transmission.
Judge Excludes Key Confession in Sept. 11 Case
Prosecutors argued the statements by the defendant, Khalid Shaikh Mohammed, were crucial evidence for the eventual death-penalty trial.
Cyabra Secures Six-Figure Annual Contract with Leading Interactive Entertainment Company to Protect its Player Community
Agreement with a major publisher in the interactive entertainment industry expands Cyabra's private-sector footprint and reflects growing enterprise demand for evidence-based analysis of coordinated online activity. New York, NY, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Cyabra, Inc. (Nasdaq: CYAB) (“Cyabra” or the “Company”), an artificial intelligence (“AI”)-powered platform that helps governments and enterprises detect coordinated manipulation and protect digital trust, announces a six-figure annual
GTA has always raised anxieties over video games and violence—here’s what the science actually says
The evidence in favor of and against video games promoting aggressive behavior is murkier than you might think
Apple's New Macs to Ship With macOS Golden Gate
The new Mac mini and Mac Studio models announced by Apple this week are "slated to ship" with macOS Golden Gate, according to Daring Fireball's John Gruber. Apple's product pages for the new Mac mini and Mac Studio models mention macOS Golden Gate features such as Siri AI, providing further evidence that the computers will ship with the latest operating system, instead of macOS Tahoe.
GLP-1s may have a host of other health benefits. Just ask these people
Here is what scientists currently know about GLP-1s, and where hype may be getting ahead of the evidence.
Record debt and election politics raise stakes for French budget
France faces a particularly perilous annual budget battle in the coming months as political parties jockey for position ahead of next spring's presidential election while increasingly anxious investors look for evidence Paris can regain control of its public finances.
WHO appoints 21 leading scientists to Science Council to help shape future health breakthroughs
The WHO Science Council is an advisory body established by the WHO Director-General to provide independent advice on high-priority scientific issues, emerging technologies, and advances in science and innovation that may affect global health. The renewed Science Council comprises 21 members serving in their personal capacities. The Council advises WHO on scientific opportunities and challenges, supports strategic foresight, and contributes to strengthening trust in science and evidence-informed decision-making.
WHO appoints 21 leading scientists to Science Council to help shape future health breakthroughs
The WHO Science Council is an advisory body established by the WHO Director-General to provide independent advice on high-priority scientific issues, emerging technologies, and advances in science and innovation that may affect global health. The renewed Science Council comprises 21 members serving in their personal capacities. The Council advises WHO on scientific opportunities and challenges, supports strategic foresight, and contributes to strengthening trust in science and evidence-informed decision-making.
Gamma-ray signal could be long awaited evidence for WIMPs
Dark matter is known to make up roughly 85% of all mass in the universe, as evidenced by the way galaxies spin and how galaxy clusters are held together under gravity. Yet despite decades of searching, ...
Syringe litter did not increase after a needle exchange ban was overturned in Pueblo, Colorado, but health services suffered
Evidence suggests that people who receive syringes from a needle exchange are less likely to dispose of them improperly.
Although research on animal production and climate is growing, bringing science to the field remains challenging
A research group from the University of São Paulo analyzed over 1,600 articles and found that research increased by 9.5% annually between 1974 and 2025. The authors advocate for regionalized solutions and public policies to bridge the gap between evidence and implementation.
Creatine: is there truth behind the hype?
Creatine has become the go-to supplement for anyone wanting to give their fitness a boost and build muscle. It’s even made it out of the gym, with influencers touting its cognitive benefits. But what’s the science behind creatine, and does the evidence stack up? Madeleine Finlay hears from science editor Ian Sample and Dr Justin Roberts, professor of nutritional physiology at Anglia Ruskin University
Largest review of its kind confirms benefits of tai chi and other Chinese exercises
Analysis finds ‘high certainty evidence’ of their effectiveness for the 1.7bn people worldwide with musculoskeletal conditions
When to trust the experts? Follow these guidelines to evaluate science on any topic
When should we trust the evidence and the experts who interpret it for us?
When to trust the experts? Follow these guidelines to evaluate science on any topic
Science works through a process of revision. As consumers, we must learn how to evaluate how mature evidence is, and always remain flexible to new findings.
Scientists reveal how proof of alien life could change everything tomorrow - Futura-Sciences
The approach depends on location. Within our solar system, probes sample rock, ice, and water on the ground. Farther out, astronomers have only starlight to go on. Close to home: the hunt for physical evidence NASA’s Perseverance rover has spent years scouring Mars for fossil biosignatures, chemical or geological traces...
Williamstown Board of Health Gets Update on 330 Cole Ave.
WILLIAMSTOWN, Mass. — The Board of Health last Monday saw evidence supporting a tenant's complaint about ventilation issues at their 330 Cole Ave. residence. Health...
Science, Faith and the Search for Our Origins
Exploring evidence for a Creator in secular culture
When machines misread science: creating guardrails for human and AI interpretation of biomedical research
npj Digital Medicine - Artificial intelligence is increasingly acting as a first interpreter of biomedical research, shaping how evidence is applied to patient care. Simultaneously, science is...
A deep dive into climate change
Some policymakers continue to question the science of climate change, despite the growing evidence of significant damage to life on land and in the ocean.Katja Matthes, director of the GEOMAR Helmholtz Centre for Ocean Research Kiel in Germany, believes the ongoing attempts to politicise climate science and discredit researchers are hindering international cooperation and public understanding. The ocean provides clear evidence of the extent to which changes are occurring, she says.“We are seeing severe, unprecedented and accelerating changes in the ocean — warming ocean temperatures, acidification and oxygen depletion — that are destabilising the most important system that makes life on this planet possible,” Matthes explains. Visible signs of these changes include the melting of ice sheets in the Arctic and Greenland. Deeper down, the growing frequency of hypoxia — or oxygen-deprived “dead zones”, where marine life can no longer survive — in the Baltic and record-high Mediterranean surface temperatures are indicators of the “dramatic warming” of the ocean, she adds.The ocean, which covers around 70% of the Earth’s surface, acts as a vital carbon sink, absorbing around 30% of the planet’s carbon dioxide (CO2) and 90% of the excess heat. However, the global ocean surface temperature has risen by an average of half a degree Celsius since 1982, according to the EU Copernicus observatory. More significant rises have been recorded in the Mediterranean, Black, Baltic and other shallower seas.Some ocean temperature increases do occur naturally, such as during El Niño events. But sustained rises can trigger extreme weather on land — including droughts, floods and catastrophic storms — while also harming marine ecosystems. Only 10% of marine species have been studied, Matthes notes, “so the consequences might be even more severe than we know.”Fostering European cooperation amid uncertaintyMatthes, who holds a doctorate in meteorology, is a professor of atmospheric physics as well as director of GEOMAR. She serves as one of Kiel’s ambassadors to Science Comes to Town (SCTT), an EU-funded programme that aims to promote science’s role in society and strengthen cross-border collaboration in research, innovation and sustainability. SCTT is hosted by the coastal cities of Kiel, Brest (in France) and Split (in Croatia).The SCTT project also provides a platform for raising awareness and understanding between scientists and the public about major issues, such as climate change. Having worked on both sides of the Atlantic, Matthes is frustrated by recent attempts to erode decades of international climate collaboration and question the credibility of research. Earlier this year, the US administration delivered a major blow to global cooperation by withdrawing from the Intergovernmental Panel on Climate Change (IPCC), the UN Framework Convention on Climate Change and other global climate organisations, claiming they were “contrary to the interests of the United States.”In addition, a US Department of Energy (DOE) report cast doubt on the latest IPCC climate assessment, which was published in 2024. As a contributing author to the IPCC study, Matthes says the DOE sought to discredit scientists like herself. “Climate change is not a matter of opinion, it really exists and we are witnessing dramatic changes,” she notes. “It’s not climate change as a whole that is being targeted, but scientists and their research.”Other US actions have also hit home for Matthes, who spent three years at the US National Center for Atmospheric Research (NCAR) in Boulder, Colorado. The White House has announced plans to close the facility, a move that was “pretty tough” due to the German scientist’s personal connections with the staff and their reputation for excellence.Changing the narrative on climate changeEurope’s scientific community remains a driving force on climate research and collaboration. As one of the world’s leading marine research institutions, GEOMAR attracts students from more than 50 countries and plays an important role in global observation initiatives that contribute to understanding and protecting the ocean basins. At a European level, GEOMAR works closely with other top marine research facilities, including France’s Ifremer, an SCTT partner in Brest. GEOMAR has also developed innovative and safe strategies for removing unexploded wartime munitions from the seabed, which release toxic substances that pose a danger to humans and the marine environment. Through the Horizon Europe MMinE-SwEEPER project, this knowledge has been transferred to the European level.These initiatives are examples of how local action can have a global impact, Matthes says, and how Europe can strengthen climate research and partnerships. “This is a chance for Europe to step up and work on climate cooperation and agreements,” she notes. “Climate change is an international problem and a real threat, and we need more speed on climate action than we have now.”Matthes believes her fellow scientists need to communicate that climate change is not only a threat, but an opportunity to find solutions. “We need to change our narrative and expand our strategic alliances with those who are willing,” she says, “and luckily there are a lot of willing people and countries.”Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.
A deep dive into climate change
Some policymakers continue to question the science of climate change, despite the growing evidence of significant damage to life on land and in the ocean.Katja Matthes, director of the GEOMAR Helmholtz Centre for Ocean Research Kiel in Germany, believes the ongoing attempts to politicise climate science and discredit researchers are hindering international cooperation and public understanding. The ocean provides clear evidence of the extent to which changes are occurring, she says.“We are seeing severe, unprecedented and accelerating changes in the ocean — warming ocean temperatures, acidification and oxygen depletion — that are destabilising the most important system that makes life on this planet possible,” Matthes explains. Visible signs of these changes include the melting of ice sheets in the Arctic and Greenland. Deeper down, the growing frequency of hypoxia — or oxygen-deprived “dead zones”, where marine life can no longer survive — in the Baltic and record-high Mediterranean surface temperatures are indicators of the “dramatic warming” of the ocean, she adds.The ocean, which covers around 70% of the Earth’s surface, acts as a vital carbon sink, absorbing around 30% of the planet’s carbon dioxide (CO2) and 90% of the excess heat. However, the global ocean surface temperature has risen by an average of half a degree Celsius since 1982, according to the EU Copernicus observatory. More significant rises have been recorded in the Mediterranean, Black, Baltic and other shallower seas.Some ocean temperature increases do occur naturally, such as during El Niño events. But sustained rises can trigger extreme weather on land — including droughts, floods and catastrophic storms — while also harming marine ecosystems. Only 10% of marine species have been studied, Matthes notes, “so the consequences might be even more severe than we know.”Fostering European cooperation amid uncertaintyMatthes, who holds a doctorate in meteorology, is a professor of atmospheric physics as well as director of GEOMAR. She serves as one of Kiel’s ambassadors to Science Comes to Town (SCTT), an EU-funded programme that aims to promote science’s role in society and strengthen cross-border collaboration in research, innovation and sustainability. SCTT is hosted by the coastal cities of Kiel, Brest (in France) and Split (in Croatia).The SCTT project also provides a platform for raising awareness and understanding between scientists and the public about major issues, such as climate change. Having worked on both sides of the Atlantic, Matthes is frustrated by recent attempts to erode decades of international climate collaboration and question the credibility of research. Earlier this year, the US administration delivered a major blow to global cooperation by withdrawing from the Intergovernmental Panel on Climate Change (IPCC), the UN Framework Convention on Climate Change and other global climate organisations, claiming they were “contrary to the interests of the United States.”In addition, a US Department of Energy (DOE) report cast doubt on the latest IPCC climate assessment, which was published in 2024. As a contributing author to the IPCC study, Matthes says the DOE sought to discredit scientists like herself. “Climate change is not a matter of opinion, it really exists and we are witnessing dramatic changes,” she notes. “It’s not climate change as a whole that is being targeted, but scientists and their research.”Other US actions have also hit home for Matthes, who spent three years at the US National Center for Atmospheric Research (NCAR) in Boulder, Colorado. The White House has announced plans to close the facility, a move that was “pretty tough” due to the German scientist’s personal connections with the staff and their reputation for excellence.Changing the narrative on climate changeEurope’s scientific community remains a driving force on climate research and collaboration. As one of the world’s leading marine research institutions, GEOMAR attracts students from more than 50 countries and plays an important role in global observation initiatives that contribute to understanding and protecting the ocean basins. At a European level, GEOMAR works closely with other top marine research facilities, including France’s Ifremer, an SCTT partner in Brest. GEOMAR has also developed innovative and safe strategies for removing unexploded wartime munitions from the seabed, which release toxic substances that pose a danger to humans and the marine environment. Through the Horizon Europe MMinE-SwEEPER project, this knowledge has been transferred to the European level.These initiatives are examples of how local action can have a global impact, Matthes says, and how Europe can strengthen climate research and partnerships. “This is a chance for Europe to step up and work on climate cooperation and agreements,” she notes. “Climate change is an international problem and a real threat, and we need more speed on climate action than we have now.”Matthes believes her fellow scientists need to communicate that climate change is not only a threat, but an opportunity to find solutions. “We need to change our narrative and expand our strategic alliances with those who are willing,” she says, “and luckily there are a lot of willing people and countries.”Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.
Business Briefcase: St. Luke’s network hospitals earn heart, stroke care recognition
BETHLEHEM — St. Luke’s University Health Network has earned national recognition from the American Heart Association/American Stroke Association for its commitment to delivering high-quality, evidence-based stroke care, according to a net…
Apollo 15 astronauts collected tiny green glass beads from the Moon in 1971; more than 35 years later scientists found evidence of water inside, changing what we knew about the lunar interior
In 1971, Apollo 15 astronauts David Scott and James Irwin noticed something unusual on the Moon: tiny green flecks scattered across the otherwise grey surface. They collected samples and brought them back to Earth, unaware that the material would decades later challenge a long-held belief about the Moon.
What happens to people’s health when air pollution is reduced?
Growing evidence that cutting coal use and bans on high-polluting vehicles are leading directly to health benefits
Are Malaysian Muslims less corrupt? PAS leader skewered over divisive politics
Critics demand evidence from Abdul Hadi Awang as official bribery data shows mixed results.
Scientists Find 3.5-Billion-Year-Old Evidence of Life, Directly Dated For The First Time
Actually incredible.
Parental mental health: Raising healthier families | Harvard T.H. Chan School of Public Health
Experts examined the factors driving parental stress and discussed evidence-based strategies to better support parents.
Black hole star? Solar-system-size 'dot' from the early universe is our best evidence yet of a brand-new type of cosmic object
The James Webb Space Telescope has identified the most promising candidate yet for a black hole star, lurking 660 million years after the Big Bang. The hypothetical entity, which shines 100 billion times brighter than a typical star, could shed light on the origins of the mysterious "little red dots."
Why You Move Matters When It Comes To Brain Health, Dementia Risk
By Dennis Thompson HealthDay ReporterTHURSDAY, Aug. 20, 2026 (HealthDay News) — It’s been said that regular physical activity can help lower risk of dementia, but a new evidence review suggests that why you move also matters. Leisure-time exercise like walking, cycling, running, swimming or playing ...
What to know about the fake election poll numbers shared and retracted by a mysterious company
Locked in a competitive reelection race, Los Angeles Mayor Karen Bass declared on social media last week that a new poll was evidence that her campaign was “gaining momentum.”
Pluto Planetary Science is the Gift that Keeps on Giving
Something's wetting the surface of dwarf planet Pluto along the northern edge of Sputnik Planitia, and planetary scientists have found a good explanation for it. A recent study of new Horizons images taken during the 2015 flyby revealed evidence that liquid nitrogen is rising up through cracks in Sputnik Planitia. That's the giant heart-shaped glacial basin we see in all the Pluto images taken by the spacecraft.
Measles Outbreak in Iowa
The Iowa Department of Health and Human Services (Iowa HHS) has confirmed 12 measles cases in Iowa with evidence of person-to-person spread. Around 5,000 exposures may have already occurred. Visit our Measles page for more information, including where exposures may have occurred.
Rock-solid evidence for the origins of birds
Stones in dinosaur stomachs may help understanding of avian evolution
How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages
Patients and researchers point to evidence that many cancer drug dosages are excessive, and that reducing the amount and frequency could save billions of dollars and prevent some of the worst side effects.
Whistleblower alleges political pressure, lack of evidence in antisemitism probes targeting schools
The complaint alleges that the investigations into some of the nation’s most prestigious academic institutions were designed to strong-arm the schools into cutting deals for political purposes.
Whistleblower alleges political pressure, lack of evidence in antisemitism probes targeting schools
A whistleblower is alleging that a Trump administration task force created to combat antisemitism pushed for settlements with Ivy League universities. That's despite government investigations the...
Trump cast a mail ballot in Florida's primary despite spreading falsehoods about mail voting fraud
Each election, tens of millions of Americans vote by mail, and evidence from court records and studies shows only a tiny fraction of those ballots are fraudulent.
Politics drove antisemitism probes against Ivy League schools, DOJ whistleblower says
A Trump administration task force on antisemitism pressured universities into punitive settlements despite turning up little to no evidence of systemic abuses, a whistleblower says.
Our Milky Way galaxy gobbled up a smaller galaxy about 11.8 billion years ago, scientists find
Scientists observing clusters of stars congregated near the Milky Way's centre have discovered evidence that our galaxy swallowed a smaller galaxy roughly 11.8 billion years ago, when the universe was less than 15 per cent of its current age.
Whistleblower alleges political pressure, lack of evidence in antisemitism probes targeting schools
WASHINGTON (AP) — A Trump administration task force created to combat antisemitism pushed for settlements with Ivy League universities despite government investigations that were rushed and incomplete or that failed to establish legal violations by the schools, a former Justice Department lawyer ...
Did life-friendly planets really form just after the Big Bang? Science stirs debate - Futura-Sciences
Standard models of galactic evolution indicated that the universe needed several billion years after the Big Bang to produce enough heavy elements for rocky planets. Vorobyov and co-author Daniel Whalen at the University of Portsmouth tested the accuracy of the time scale using computational models. Their team found evidence that...
Scientists may have finally proved that “empty” space isn’t really empty
A magnetar’s colossal magnetic field may have revealed a quantum effect predicted by Werner Heisenberg nearly 90 years ago, in which seemingly empty space alters the behavior of light. If confirmed, the discovery could offer the first direct evidence of vacuum birefringence and open a new window into the strange physics of the quantum vacuum.
Trump blames vandals for damaged grass in the spot where he held his July 4 celebration
Trump has repeatedly blamed vandals for damage to his renovation projects in the nation's capital, often without evidence and sometimes despite opposing accounts from his officials.
AMS Science Preview: Earth Energy, Neighborhood Hurricane Warnings
New research published in AMS journals discusses neighborhood-level forecasting of hurricane impacts, how deforestation in New Guinea affects North American temperatures, evidence climate change is…
Hubble Solves Merger Mystery From Milky Way’s Early Years
New Hubble data shows definitive evidence of a dwarf galaxy merging with the young Milky Way in the earliest phases of its evolution.
Cialis is an erectile dysfunction drug. Could it also help you live longer?
In some wellness circles, tadalafil is promoted as a longevity drug. There is evidence showing a link between it and a lower risk of death in men, but there are no well-controlled trials in humans.
Paid paternity leave is pediatric preventive care
“A growing body of evidence shows that fathers make unique, independent contributions to children's health and development,” writes pediatrician Nishant Pandya.
After Half A Century, Physicists Find The Strongest Evidence Yet For An Exotic 'Glueball' Particle
An "unprecedented form of matter".
Australia needs more people who think like scientists. Here’s what that means
Science equips us with the tools to reason, evaluate evidence, and make informed decisions in a complex, changing world.
Opinion: Could the fight for clean water bridge the gap between science and MAHA?
Clean water offers a place to replace polarized rhetoric with cooperation, evidence and measurable results.
Nancy Cartwright, philosopher: ‘People distrust science because they feel the system has abandoned them’
The thinker reflects on evidence-based science and advocates for combining methods to put research to good use in economics or public health
The Great Barrier Reef isn’t dead yet. According to News Corp that makes climate science a ‘pseudo-religion’
‘High coral cover is evidence of recovery and resilience, not evidence that the disturbances causing mortality didn’t happen’, scientist says
Congress must stop the politicization of peer review and American science
American scientific leadership was built by allowing evidence to prevail over ideology.
Congress must stop the politicization of peer review and American science
American scientific leadership was built by allowing evidence to prevail over ideology.
States Take Uneven Approach to Convictions Built on ‘Junk Science,’ State Court Report Examines
States are implementing divergent legal frameworks regarding criminal convictions predicated on forensic evidence subsequently identified as 'junk science,' resulting in varied outcomes for incarcerated individuals seeking relief, according to a recent analysis by State Court Report.
After 50 Years, Physicists Find Strong Evidence For What Really Holds Matter Together
A discovery half a century in the making.
After 50 Years, Physicists Find Strong Evidence For What Really Holds Matter Together
A discovery half a century in the making.
AI needs science’s search history
“Actually, that’s where the gold is,” said Alasdair Russell, my graduate school friend who leads a pre-clinical genome editing group at Cambridge. He was talking about the winding road of science that is omitted from published papers. “When you’re discussing how to do the experiment, and why this way is better than another way, and what does the data really mean? I know what it shows, but what does it mean?” At RAAIS 2026, he described how his group has begun logging the twisting path of discovery as it happens, recording the verbal and written exchanges that normally disappear. Ideas become nodes in a living graph: they branch when a meeting produces two plausible experiments, merge when separate lines of evidence converge, and go dark when someone quietly stops pursuing them. In his implementation, one agent scores novelty, while another tries to learn “how scientists think and how they navigate through a complex world of data,” so that high-potential nodes can trigger deeper investigation. As frontier AI labs deploy agents toward scientific discovery, giving AI authentic scientific taste remains a trillion-dollar dilemma. The bottleneck is that the record we have kept for centuries of science might be insufficient to get us there. The experiments that never make the paper Peter Medawar, 1960 Nobel laureate and “father of transplantation,” asked in 1963 whether the scientific paper was a fraud, and answered yes: the form of the paper misrepresents the thinking that produced it. Sixty years on, the diagnosis is unchanged. A paper presents a clean progression from hypothesis to result to conclusion. Lost along the way are the unconventional theories, the abandoned or unaffordable methods, and the underwhelming and inconclusive data. It reads like a browser history with every dead end deleted: the ten open tabs, the four rephrased queries, the wrong turn down a subforum. All scrubbed, leaving one clean path from question to answer as the canonical path. What has changed since then is that the discarded material is now worth something. No high-impact journal wants these artifacts, but raw trial and error is the most likely source of the training data required to develop scientific intuition, or what researchers call taste. Earlier attempts to capture the discards were motivated by scientific integrity. The Journal of Negative Results in Biomedicine launched in 2002 to publish rigorous studies that disputed established models or exposed ineffective treatments. Its archive preserved negative conclusions after they had become papers, rather than the live alternatives and arguments that produced them. BioMed Central closed it in 2017, saying the mission had been served now that other journals publish null results. A less generous reading is that in fifteen years it published around 200 papers because almost nobody wants to read a negative result, let alone write one up when it will not count toward academic tenure. AI models are different. Even an uninteresting negative result can be useful, provided it is labeled. Earlier this year, Anthropic put a version of this to the test. The company pulled 129 decision points from real Claude Code sessions between January and March 2026, showed models the work up to a human detour, and asked what should happen next. Claude Mythos Preview beat the human choice 64% of the time, while Opus 4.5 managed 51%. The comparison was tilted toward the models because Anthropic deliberately chose moments where the human decision had room for improvement. On 127 further scenarios where the human action was already strong, the models improved on it only about 20% of the time. The study was possible because Anthropic’s researchers work inside a tool that logs by default. The reasoning, detours and outcome are produced in the same working environment. Biology has no equivalent. Its reasoning happens in hallways, at benches, in Slack threads and on whiteboards, while the outcome arrives weeks later somewhere else. The record has to emerge from the work itself. Ask scientists to reconstruct it afterwards and we’ll create another polished account. Subscribe A log is not a label Before any of this becomes training data, a negative result has to say what failed. The first paper published in the Journal of Negative Results in Biomedicine examined 234 negative studies across five leading medical journals. Only 30% discussed statistical power, and half clearly defined a primary outcome. Tell a model an experiment failed, without telling it whether the assay was underpowered, a reagent had degraded, or the hypothesis was simply wrong, and it will learn noise with confidence. Decision histories have a second missing label too. When a lab considers five experiments and runs one, only the chosen branch returns an outcome. The other four are experimental counterfactuals. Researchers call this the selective labels problem: the data reveal results only for the actions someone chose to take. Such a record can teach a model to imitate a lab’s taste, but it cannot establish that the taste was good. It also smuggles local constraints into general lessons. A lab that never ran cryo-EM because it did not own a microscope teaches a model that cryo-EM is rarely the right call. Alasdair’s nodes preserve the candidate set, which is the necessary first step. To be useful, each decision record needs six fields: The evidence available at that moment, and nothing that arrived later. The candidates considered, including the ones dismissed in a sentence. For each candidate: the expected result, the confidence attached to it, and the cost in time and money. The route chosen, and the reason. What happened next. How the evidence changed the scientist’s view. These must be timestamped before the outcome, because hindsight turns uncertainty into inevitability. Disagreement also has to survive. Averaging three scientists into one clean rationale reproduces exactly the information loss we are trying to fix. But there is an obvious failure mode here. Once decisions are logged and scored, people log for the record post-facto. Anyone who has watched an electronic lab notebook fill up with retrospective tidying knows how quickly a research tool becomes a compliance exercise. A record that costs a scientist ten minutes of honest reflection per decision is worth far more than one that costs an hour of performance. A publication initiative called Registered Reports offers a useful starting point. Here, researchers submit their rationale, methods and analysis plan for peer review before the data exist, and the journal commits in principle to publish if they follow the approved plan. Nature has now expanded the format across every field it covers. This approach to paper writing timestamps intent before the outcome, but it freezes one plan. A useful search history must also preserve how the plan changed, which alternatives were rejected, when, and on what evidence. Subscribe Run the runner-up Autonomous labs show what happens when decisions and outcomes are connected in a loop. Liverpool’s mobile robotic chemist ran 688 experiments over eight days in a ten-variable formulation space. A batched Bayesian search used each result to choose the next experiments and found photocatalyst mixtures six times more active than the starting formulations. Every completed experiment changed what the system did next. The robot optimized within a goal and search space that humans had already chosen. It did not decide which scientific question mattered. So what this work demonstrates is narrower, but still useful: a search history pays off when the options return standardized outcomes quickly. Open-ended biology is harder because branches can take weeks and the discarded alternatives may never be run. Some exploration therefore has to be bought. Where two branches are plausible and the stakes justify the cost, a lab should sometimes run the runner-up. Otherwise the record captures what today’s scientists usually chose and stays silent on what they systematically overlooked. A funder could ring-fence a small fraction of a grant for the branch not taken, provided that the decision record and the outcome are both deposited. That costs money, but so does having every lab rediscover the same abandoned path. Test whether taste transfers When it comes time to evaluate if our new AI system exhibits taste, the comparison should run across laboratories and fields. At selected decision points in a live research campaign, we should freeze the six fields: the evidence, the candidates, expected results, confidence, costs and the choice made. Experts then rank the options before the outcomes are known, and those outcomes are checked independently later. We could give models one of two diets - papers alone, or papers plus decision histories - and ask them to rank the next experiment on unfamiliar projects. Then, we score information gained per dollar and week, calibration, and how quickly weak branches are abandoned. If histories improve choices only inside the lab that produced them, they amount to useful organizational memory. If they improve choices on unfamiliar problems elsewhere, Alasdair’s group will have captured something science has never managed to write down: a transferable record of taste. Until that happens, a scientific search history is a promising record, not yet a training set.
Asia-Pacific parliamentarians urge bolder action for universal health coverage, climate resilience and responsible AI
Parliamentarians representing 16 countries from across the Asia-Pacific region concluded the Ninth Meeting of the Asia-Pacific Parliamentarian Forum on Global Health (APPFGH) today, reaffirming their key role in advancing universal health coverage (UHC) amid the risks and opportunities posed by AI and climate change. In adopting the Phnom Penh Communiqué, parliamentarians urged fellow legislators regionwide to strengthen sustainable financing for UHC to widen access to health for all, including the most vulnerable populations; promote responsible governance of AI amid ethical concerns over this fast-evolving technology; and build climate-resilient health systems to anticipate and respond to mounting pressures ranging from rising sea levels in coastal areas to air pollution and other environmental degradation.The National Assembly of Cambodia, with support from Cambodia’s Ministry of Health and the World Health Organization (WHO), hosted the Forum in Phnom Penh from 11 to 13 August 2026 – the first time the Forum has convened in a Mekong country.Parliamentarians urge action to close gaps in accessIn the Communiqué, parliamentarians recognized that at-risk and marginalized groups are the ones most severely affected by gaps in access to health services. These groups include people living in poverty, women and children, persons with disabilities, older people, migrants, refugees, and those in rural, remote or island communities. The Communiqué urges fellow parliamentarians and policy-makers to advocate for laws and policies that support sustainable financing to protect people from financial hardship, with a focus on primary health care, prevention and equity. "The Communiqué is a call to action. It sets out ambitious, concrete measures that deliver meaningful impact on the ground. We are all accountable for advancing universal health coverage and translating our commitments into tangible results. Cambodia is fully committed to advancing UHC, including the promotion of ‘healthy people, prosperous country’ campaign,” said Samdech Maha Rathsapheathika Thipadei Khuon Sudary, President of the National Assembly of the Kingdom of Cambodia.His Excellency Professor Chheang Ra, Minister of Health of the Kingdom of Cambodia, highlighted the need for collaboration beyond the health sector. “Universal health coverage cannot be achieved by the Ministry of Health alone. It requires support, particularly from parliamentarians, across political, legislative, financial, social protection, education, infrastructure, and environmental domains. While each country follows its own path, one factor is universally critical for success: strong governance and leadership. We all believe in this principle, and in our respective political roles, we remain committed to strengthening these key success factors to ensure that no one is left behind.”Promoting responsible AI adoption Parliamentarians acknowledged that, while AI has already demonstrated its ability to improve access to health services and support delivery, careful and ethical governance is necessary to safeguard quality, safety, privacy and public trust. This underscores the importance of parliamentarians in promoting legal and regulatory frameworks addressing liability, records ownership and data governance, while embracing innovation that protects ethical practice.“Without strong governance, safeguards for privacy and data security, sustainable financing, and attention to those most at risk of exclusion, new technologies may widen existing gaps instead of closing them. This is why parliamentarians matter. We pass laws. We approve budgets. We scrutinize government action. We represent communities. We can ask whether health services are reaching rural, remote, ageing, poor, and marginalized populations. We can ask whether innovation is being guided by equity, evidence, and ethics,” said Hon. Man Hee Lee, President of the Asia-Pacific Parliamentarian Forum on Global Health.Building climate-resilient health systemsParliamentarians also reiterated that the climate crisis is a direct threat to people’s health and to achieving UHC more broadly, deepening the same gaps in access already faced by at-risk and marginalized communities. They recognized the need for WHO Member States to ensure sufficient national appropriations and oversight, and for parliamentarians to raise awareness in their constituencies and mobilize local action in building climate-resilient and sustainable health systems.“Universal health coverage, climate change and AI cannot be addressed in isolation. The same communities struggling to access health services today are often the ones most exposed to climate shocks, and most in need of the opportunities AI can offer if this technology is governed responsibly,” said Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific. “Having served previously in this Forum myself as a parliamentarian from Tonga, I recognize how the Phnom Penh Communiqué reflects the shared resolve of legislators across the Asia-Pacific region: the laws parliamentarians pass and the budgets they approve help ensure this progress reaches the people who need it most.”As the Forum drew to a close, delegates reflected on what they would carry back to their own parliaments and constituencies.“I wish to share three points here worth carrying home from Phnom Penh: we need to invest in primary health care as the foundation of coverage; we need to remove the barriers that keep people from care, whether financial, geographic or social; and we need to build systems that are inclusive by design, protecting those most at risk of being left behind,” added Hon. Ouch Borith, First Vice-President of the Senate of the Kingdom of Cambodia.###Notes for editors:The Asia-Pacific Parliamentarian Forum on Global Health (APPFGH) is a platform for parliamentarians to exchange ideas, build political will, strengthen capacity and foster collaboration towards sustainable health action. This was the ninth meeting of the APPFGH, with the theme “Universal Health Coverage in the era of Climate Change and Artificial Intelligence”. Target 3.8 of the Sustainable Development Goals calls on countries to achieve universal health coverage, including financial risk protection, access to quality essential health services, and access to safe, effective, quality and affordable essential medicines and vaccines for all. In the Western Pacific, UHC service coverage index (SDG 3.8.1) rose from 63 in 2000 to 81 in 2023 (figures include Indonesia), and roughly one in four people in the Western Pacific have experienced financial hardship (SDG 3.8.2). Progress towards UHC in the Asia-Pacific region remains uneven, with hundreds of millions of people still lacking access to essential health services or facing financial hardship due to health-related expenses. Strengthening the role of parliaments – through legislation, financing and oversight – is central to closing this gap and accelerating progress towards UHC across the region.Parliamentarians participating in APPFGH in Cambodia this week include: Hon. Pehin Dato Adanan YUSOF, Brunei Darussalam; Hon. Rosmawatty ABDUL MUMIN, Brunei Darussalam; Hon. LORK Kheng, Kingdom of Cambodia; Hon. YOS Phanita, Kingdom of Cambodia; Hon. KHOUN Khundy, Kingdom of Cambodia; Hon. HENG Halim, Kingdom of Cambodia; Hon. KHOENG Noupheap, Kingdom of Cambodia; Hon. SENG Nhak, Kingdom of Cambodia; Hon. LY Sukry, Kingdom of Cambodia; Hon. NHOEURN Raden, Kingdom of Cambodia; Hon. Dr Ratu Atonio LALABALAVU, Republic of Fiji; Hon. Vijay NATH, Republic of Fiji; Hon. Man Hee LEE, Republic of Korea; Hon. Dr Jiho CHA, Republic of Korea; Hon. Jonghun BAEK, Republic of Korea; Hon. Youngsuk SEO, Republic of Korea; Hon. Dr Phayvanh KEOPASEUTH, Lao People’s Democratic Republic; Hon. Suhaizan Bin KAIAT, Malaysia; Hon. Dr Perpetua KONMAN, Federated States of Micronesia; Hon. Ganmaa DAVAASAMBUU, Mongolia; Hon. Charmaine SCOTTY, Republic of Naoero; Hon. Vincent Ambance KUMURA, Papua New Guinea; Hon. Dr Edwin CRUZADO, Republic of the Philippines; Hon. AUUAPAAU Mulipola Aloitafua Mulipola, Samoa; Hon. ASIATA TAVUI Tafu Salevao, Samoa; Hon. Dr Alani Petelo TANGITAU, Tonga; Hon. Paul PAOLO, Republic of Vanuatu; Hon. Franklyn Ezra WILLIAM, Republic of Vanuatu.For more information, contact: WHO Regional Office for the Western Pacific: wprocom@who.int National Assembly of the Kingdom of Cambodia (International Relations Department): ir.nacambodia@gmail.com
What Science Day 2026 revealed about the next chapter of science policy
Science Day 2026 explored how stronger institutions, trust and science-policy partnerships can turn evidence into action for 2030 and beyond.
Have physicists finally discovered glueballs? New evidence points to yes.
“It’s the strongest evidence yet that particles dominated by a glueball component can exist in nature.”...
Scientists find evidence for two origins of life on Earth
Scientists probing life’s deepest origins have uncovered evidence that the first free-living cells may have emerged not once, but twice. The findings suggest a striking possibility: life may share one ancient genetic code, yet have undergone two separate transitions into free-living existence.
Star cluster discovery could change how scientists measure the universe
University of Missouri researchers have uncovered evidence that challenges one of astronomy's most trusted assumptions, a breakthrough that could reshape how scientists measure galaxies and reconstruct ...
ND Expert on democracy: Can better civics education restore voter dissatisfaction over political corruption?
This summer, America celebrated the 250th anniversary of the signing of the Declaration of Independence, widely recognized as the formal founding of our nation and one of the early stages of establishing a democratic government. Over the past two decades, however, democracies all over the world have struggled with a lack of clear support. Democracy scholars have referred to these challenges as evidence of backsliding, a phenomenon that has many political and social scientists concerned, including Notre Dame development economist Enrique Seira Bejarano.
Illinois should adopt Michigan's science of reading approach
Michigan's new law requires elementary reading teachers to train in evidence-based instruction, aligning with the science of reading to combat literacy crises.
The U.S. Healthcare System is Already Mostly Socialized
Now that Abdul El-Sayed is the Democratic nominee for Michigan’s open Senate seat, the outcome of this crucial race will depend mainly on two things: Whether Republicans succeed in demonizing El-Sayed because he’s brown and a Muslim, and whether they succeed in demonizing him as a left-wing radical. I will defer for the now the question of whether bigotry will be effective this year, although I will address it another day. What I want to address instead is El-Sayed’s signature issue — healthcare. Yes, El-Sayed advocates Medicare for All, a position the usual suspects denounce as “socialism.” I will get to the politics of his stance soon. Today, however, I want to talk about the substance. We should be clear that El-Sayed doesn’t even call himself a socialist. On the contrary, he explicitly disavows the label, saying “I’m a capitalist who just knows about capitalism”. In fact, as I explained in a previous post, the policies that El-Sayed advocates qualify him as a social democrat, not a socialist. Still, El-Sayed advocates a system under which the government would pay almost all medical expenses. Isn’t that socialism? Well, if that is the criterion then much of U.S. healthcare is already socialist. In fact, the government’s role is so large that U.S. healthcare is better described as partially privatized socialism than as anything resembling a free market. Let’s start with the raw numbers on health insurance, which pays the bulk of Americans’ medical expenses. Americans receive health insurance either from private companies or from public programs, overwhelmingly Medicare and Medicaid. Here’s what the breakdown of coverage and spending between private and public looked like in 2024: While a majority of Americans with health insurance get it from private companies, well over 100 million of us are covered by government programs instead. And these government programs pay more total dollars for medical bills than the private insurers do. Why do government programs that cover a minority of the population account for a majority of health insurers’ outlays? Mainly because Medicare covers seniors, and we’re expensive. Also, while Medicaid covers many younger Americans, disabled and elderly beneficiaries account for most of its spending. Even by the raw numbers, then, U.S. health insurance looks as much public as private. But that understates the government’s role: Private health insurance in the U.S. is both highly regulated and heavily subsidized. This is obviously true for the insurance coverage purchased by tens of millions of Americans through the exchanges established by the Affordable Care Act. But employment-based health insurance, which covers 161 million Americans, is far more of a government creation than most people realize. For employment-based insurance exists largely because of huge implicit government subsidies that come with major strings attached. Here’s how that works. If your employer pays you $10,000, that’s taxable income. But if your employer pays $10,000 toward a company health insurance plan that meets certain criteria, it isn’t taxable. That’s a huge effective subsidy, running at more than $300 billion a year. Take that subsidy into account, along with the more than $100 billion per year spent subsidizing policies purchased under the ACA, as well as the outlays on Medicare and Medicaid, and net effect is that the government pays for more than two-thirds of Americans’ health insurance. Granted, there are strings attached. Roughly speaking, employment-based health plans can’t discriminate based on medical history — that is, they can’t deny coverage to employees with pre-existing conditions — and they also can’t offer the plans only to highly compensated employees — a health plan that is only for the C-suite is considered taxable income. So given the restrictions of the federal tax code, employer-based health insurance is a lot like Obamacare, which also prohibits discrimination based on medical history and provides subsidies to make insurance affordable to lower-paid workers. The fact is that virtually all of private healthcare insurance is already well under some form of government control through regulation and tax subsidies. How should we think about this system? First of all, is Medicare socialist? Don’t tell anyone, but the way Medicare operates — it covers every senior’s medical expenses, whatever they turn out to be, while being funded by taxes that depend on one’s income — could be summarized by the old Marxist slogan “From each according to his ability, to each according to his need.” And back in 1961, when Ronald Reagan was the face of a last-ditch effort by the American Medical Association to block the creation of Medicare, he denounced Medicare as “socialized medicine” and warned that it would destroy our freedom. In reality, American freedom survived until Jan. 20, 2025, while Medicare is immensely popular, with an 82 percent favorable rating in the most recent KFF survey. Medicaid, government health insurance for lower-income Americans, comes in at 73 percent. This is in sharp contrast to public views about private insurers, who are widely disliked if not hated and accused of denying essential care. Furthermore, if Medicare is socialism, then the whole U.S. health insurance system, with the government paying most of the bills and placing conditions on private insurers, is almost equally socialist. If you insist on calling any program the government pays for and regulates socialist, then U.S. healthcare would best be described as a partially privatized form of socialism. And one must ask, what is the point of the part that is privatized? Do private insurers add anything positive? Or are they simply parasites, skimming off money that could have been paying for care? The case for viewing insurers as parasites is strong. Many Medicare benefits are now delivered via Medicare Advantage, that is, plans paid for by the government but run through insurance companies. MedPAC, an independent advisory commission, estimates that last year Medicare Advantage plans were overpaid by $84 billion, thanks to practices such as “upcoding,” in which patients’ health problems are overstated to get larger sums from Medicare. Assessing the waste from employer-based insurance is harder, but most evidence suggests that private insurers have substantially higher administrative costs than Medicare does. Furthermore, the complexity of private insurance, with multiple payers all trying to deny care when they can, is a huge burden both on providers — doctors, nurses, and hospitals — and on patients. What do private insurers offer to compensate for these costs? One must go through intellectual contortions to avoid the conclusion that they are, in fact, parasites. Which brings me back to El-Sayed. In supporting Medicare for All, he’s basically calling for an end to the partial, parasitic privatization of a healthcare system that is already hugely dependent on public funding. When one looks at it that way, it’s not at all a radical proposal. Admittedly, the political lift requires overcoming the opposition to higher taxes to pay for Medicare for All. Political realism rather than economics was the reason I and many other progressives supported Obamacare, with all its complexities, rather than demanding an immediate move to Medicare for All. But the political calculus may very well have shifted since the 2000s, as Americans are fed up with a system of unaffordable premiums, rampant claim denials, and byzantine claim administration. Moreover, funding healthcare insurance through taxation would allow for a much more progressive distribution of the cost. That is, compared to the present system, middle-income households would pay less as high-income households would pay more. And the U.S. would stop wasting large sums on pointless administrative costs. So let’s be clear: El-Sayed’s healthcare platform is perfectly reasonable on the merits of cost, fairness and health efficacy. And with private insurers never more hated, while millions of Americans are losing their health insurance, 2026 may be its time. MUSICAL CODA
Formulogic Debuts in Singapore with Science-Driven Barrier Care for Southeast Asia's Sensitive Skin
Formulogic, a science- and evidence-driven dermocosmetic brand dedicated to sensitive skin, developed through dermatological research and clinical validation, officially debuted in Singapore at CONNEX-C Asia 2026, jointly organized by Society of Cosmetic Scientists (Singapore) (SCSS) and Lee Kong Chian School of Medicine, unveiling its evidence-based barrier care philosophy and a comprehensive skincare system designed specifically for Southeast Asia's unique climate and skin concerns.
Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution
The $50 billion federal Rural Health Transformation Program is set to flood rural America with new AI health tools. That’s despite little evidence on whether health-related AI can improve access to care and patient health in those communities.
Reinventing health communication for the digital era
Nature Medicine - The commissioners behind the Nature Medicine Quality Health Information for All Commission explain why improving access to accurate, timely and evidence-based information is now...
Tracking Health Security Progress and Building Resilience in Africa
The AHS Index is an objective, evidence-based tool that helps countries and organizations set priorities and identify where investments can have the greatest impact. As health threats become more complex and interconnected, maintaining momentum will require sustained investment, stronger partnerships, and continued political commitment.
AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice
AbCellera has reported phase 2 results “beyond even the most aggressive upside scenario” that its CEO dared to consider, boosting the biotech’s chances of challenging Astellas and Bayer for a women’s health market. The phase 2 clinical trial compared ABCL635, an antibody targeting NK3R, to placebo in patients with hot flashes caused by menopause. Investigators enrolled 92 postmenopausal women experiencing a mean of about 10 moderate or severe hot flashes per day. By Week 4, the number of moderate or severe hot flashes had fallen by a mean of 8.8 on ABCL635 and by 3.5 on placebo. That statistically significant, placebo-adjusted reduction of 5.3 hit the trial’s primary endpoint. The level of efficacy also cleared the bar set by existing drugs. While cross-trial comparisons can be misleading, AbCellera CEO Carl Hansen, Ph.D., had seen enough to start hyping the program. “We now view ABCL635 as a potential best-in-class non-hormonal therapy with strong differentiation against approved NK3R competitors across all important dimensions, including efficacy, safety, dosing and convenience,” Hansen said on a Monday morning conference call with investors to discuss the data. “We believe ABCL635 is now a highly de-risked program.” Last week, Hansen used AbCellera’s earnings call to set expectations for readout, with the CEO defining success as a clean safety profile and efficacy comparable to the two approved small molecules. The data vaulted over that bar. Astellas linked (PDF) one of the small molecules, Veozah, to placebo-adjusted reductions in hot flash frequency of 2.1 and 2.6 at Week 4 of its two phase 3 trials. Bayer reported (PDF) placebo-adjusted reductions of 3.04 and 3.29 at Week 4 of pivotal studies for its small molecule, Lynkuet. At 5.3, the placebo-adjusted reduction in AbCellera’s trial comfortably cleared the standard set by the incumbents. Veozah and Lynkuet came to market based on evidence of their ability to reduce the frequency and severity of hot flashes. AbCellera’s phase 2 study covered both endpoints, with the Canadian biotech reporting a mean reduction in severity of 1.4 points at Week 4 on ABCL635, compared to 0.3 points for placebo. Again, the placebo-adjusted result compares favorably to data on Veozah and Lynkuet. Analysts shared Hansen’s enthusiasm for the data. The phase 2 results “firmly validate ABCL635 as a potentially best-in-class treatment,” BMO Capital Markets analysts said in a note to investors Monday. ABCL635’s apparent efficacy edge “is likely attributable to the higher dosing/target engagement the asset is able to reach vs. the oral agents due to its wider therapeutic index,” the analysts added. The analysts, who model $2.3 billion in unadjusted peak sales for ABCL635, flagged the safety profile as another positive of the phase 2 readout. While Veozah carries a boxed warning for liver damage, nobody on ABCL635 in the phase 2 trial had elevated liver enzymes or bilirubin values. If replicated in phase 3, the lack of a liver signal could allow approval without the monitoring requirements imposed on Veozah. Investors appeared equally enthused, sending AbCellera's stock up 32% to $9.21 in premarket trading Monday from a Friday closing price of $6.93. Next, AbCellera will collect the Week 12 data and talk to its advisors about further development. The results open up “a wide variety of possibilities of how we might take this forward into phase 3 studies to truly maximize the value of the asset and make sure that ABCL635 is able to demonstrate its differentiation potential,” Sarah Noonberg, M.D., Ph.D., AbCellera’s chief medical officer, told investors.
Preventing a Health Service Continuity Crisis in Syria - Donor Briefing Note - Evidence period: 2025 and 2026 Impact of Underfunding of Health Sector Syria June 2026
Other in English on Syrian Arab Republic about Health and Humanitarian Financing; published on 16 Jul 2026 by Health Cluster and WHO
Meteorite that smashed through a New Jersey roof reveals clues to life’s origins
A rare meteorite that crashed through a New Jersey roof contains evidence of ancient salty fluids, organic compounds, and amino acids from a primitive asteroid. Its pristine chemistry could offer new clues about how space rocks helped supply early Earth with some of the ingredients needed for life.
Missouri should dump the use of junk science in its courtrooms
Missouri patients deserve confidence that the science presented in our courtrooms is credible, reliable and grounded in evidence. When unreliable expert testimony is allowed to influence juries, the consequences extend far beyond the courtroom. Manufactured claims can scare patients away from proven treatments and make medical innovators think twice about investing in research and development […]
Heart experts fear Trump’s FDA is ‘ignoring decades of evidence’ as it authorizes new nicotine pouches
The FDA has authorized four new flavored nicotine pouches, highlighting their potential to help adults stop smoking cigarettes. The American Heart Association shared its concerns with the move, saying "key questions" remain unanswered.
These 'five pillars' for living healthier longer are easy and affordable
Longevity has become a bit of a buzz word, and has become increasingly aligned with the tech industry. But while it remains unclear whether the billions of US dollars being invested in life-extending bioscience is something any of us can access, a timely report from Harvard Medical School reminds us what we can do on our own – and it's backed by a huge body of evidence.
Back-to-school brain health: Expert tips to boost learning and memory
A UAB neuroscientist shares evidence-based tips on sleep, stress management and study strategies that can improve learning, memory and academic performance throughout the school year.